Načítá se...
Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
Primary biliary cholangitis (PBC) is an autoimmune liver disease associated with altered lipoprotein metabolism, mainly cholesterol. Hypercholesterolaemia, a major modifiable risk factor for cardiovascular disease in the general population, occurs in 75%–95% of individuals with PBC. The impact of hy...
Uloženo v:
| Vydáno v: | Frontline Gastroenterol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788128/ https://ncbi.nlm.nih.gov/pubmed/31656566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101124 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|